India’s first indigenous Covid-19 vaccine Covaxin, codenamed BBV152, is safe, immunogenic and has no serious adverse effects, medical journal Lancet has said while publishing the vaccine’s phase 2 trial results.
Copyright © 2024 | WordPress Theme by MH Themes